United States · FDA National Drug Code directory
PACLITAXEL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67457-937_a7b44e58-9df3-4a4e-b521-99f4d4149457
- Product NDC
- 67457-937
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- PACLITAXEL
- Labeler
- Mylan Institutional LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251009
- Source listing expiry
- 20271231
Source-listed ingredients
- PACLITAXEL — 100 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 mL in 1 VIAL (67457-937-50) · 67457-937-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →